ABOUT OUR PRODUCT
WHAT’S ALL THE HYPE HEMP ABOUT ?
Right at the forefront of the global cannabis industry with a revolutionary international patent-pending product, the STICKIT® brand was first conceived and developed in our R&D lab in Israel as a mean of enabling people to smoke cannabis, by simply inserting the active material into any existing cigarette.
It followed the observation that traditional rolling is often inconvenient, time consuming and generally not conducive to casual or impromptu cannabis consumption.
In other words, new users, medical or recreational, do not know how to roll a joint.
Derived from a proprietary production process, STICKIT® offers condensed cannabis oil in a unique matrix giving it just the right rigidity, similar to a toothpick that instantly converts a regular cigarette into a cannabis/hemp cigarette.
TAKE IT EASY
Once inserted, STICKIT® burns at the same rate as the cigarette. That means no particles, minimum ash and a fun & easy experience.
TAKE IT EVERYWHERE
Once inserted, STICKIT® burns at the same rate as the cigarette. That means no particles, minimum ash and a fun & easy experience.
TAKE IT WHEN YOU NEED IT
STICKIT® terpene combinations work in synergy with the cannabinoids giving a precise target and scent. Colors printed on the STICKIT® itself will indicate these features, enabling the consumer to choose which one is preferred, wherever he or she happens to be and per situation.
FOCUS
FOCUSING STICKIT®
Limonene, Myrcene, Ocimeme) Myrcene is considered to be calming and relaxing Ocimene, with its orange aroma also promotes elevated moodWAKE UP AND SMELL THE FUTURE
The options are endless and we have so many plans and ideas for STICKIT®.
Currently we are working on new STICKIT® whisky, chocolate
and bubblegum aromas and flavors, and more coming soon…
ENERGY
STICKIT® CREATING AN ENERGETIC SENSATION
A-Pinene is considered to promote alertness, euphoria, creativity and reduce memory deficits. Terpinolene is anti-fungal, anti-proliferative inhibits cancer cell growth) and is considered to be a potent treatment to allergy and asthma and more. Limonene is believed to provide anxiety and stress relief as well as being an antidepressant and promote elevated mood.
CALM & SLEEPY
STICKIT® PROMOTING RELAXATION AND SLEEP
Calm & Sleepy - Linalool, B-Caryophyllene, Humulene) Linalool is a natural sedative, promoting deep calm relaxation, drowsiness and sleep. LInalool lowers anxiety and depression symptoms and is also used as a pain reliever. B-Caryophyllene with its spicy, peppery aroma, treats inflammation, fungi and in some cases even Cancer. Bio-Humulene compound has proven to be an effective anti-cancer, anti-inflammatory, antibacterial, and appetite suppressant. OPPORTUNITY THAT STICKS
STICKIT® developed and will soon be marketing a revolutionary product for medical and recreational cannabis users (CBD).
This advanced product has already drawn the attention of various international corporations, offering expanded distribution contracts (in addition to existing contracts) and willing to purchase millions of dollars worth of inventory.
The Cannabis market in Europe and in North America only, is expected to reach
approx. $80 billion per year, in 2024, making STICKIT the right company at the right time.
MARKET POTENTIAL
MARKET POTENTIAL
The Cannabis market holds a great potential. Whereas most existinting products are old fashioned and overpriced, offering a poor customer experience – recent groundbreaking technologies offer a variety of exciting new cannabis products and applications.
The Cannabis market is one of the world’s fastest growing and intriguing markets, shifting from minor corporate activity less than a decade ago, to a flourishing market with more and more companies worth billions of dollars.
New and innovative categories, products and applications appeal to new and existing Cannabis users, both medical and recreational.
Commercial Cannabis trade is regulated and legalized in a constantly growing number of states and countries across the US and Europe.
Worldwide Cannabis sales are already booming.
EXCEPTIONAL TECHNOLOGY
- The STICKIT prototype was developed and tested by hundreds of test users.
- STICKIT’s highly innovative technology enables a proprietary production process,transforming condensed cannabis oil into a unique new product offering users a controlled, precise and effective experience.
- STICKIT may be used as a medicinal platform in the near future – conveniently aiding patients treated with inhaled medicines.
- International patent pending.
STICKIT offers a great variety of compounds, concentrations, aromas and tastes to precisely fit any need or desire. - STICKIT addresses a wide range of needs, moods and sensations (Energetic, focused, calm&sleepy and more) with various dosages (10-30 ml) to ensure an effective and controlled user experience.
- Matrix giving it just the right rigidity, similar to a toothpick that instantly converts a regular cigarette into a cannabis/hemp cigarette.
GLOBAL PRODUCTION
GLOBAL BRANDING
GLOBAL PRODUCTION
- Cannabis consumers – both medical and recreational – have been shown to better relate to a consistent and precise experience using Cannabis.
- STICKIT’s ability to define and consistently control its compounds and their effect is a unique and exclusive quality in the current Cannabis market – giving the company and its partners the opportunity to build a strong global brand.
- STICKIT® technology allows adjustments in every aspect of the final product (active substance dosage, potency, flavor and aroma) to fit any local regulation or consumer preference and to locally manufacture in any market destination:
- Eliminating complex and expensive import/export handling Saving the cost of taxes
- Offering worldwide consumers an accessible and fair price
GLOBAL CANNABIS MARKET REVIEW
Analysts all over the world express high optimism regarding the Cannabis market size and estimate its continued growth in North America, Europe and Asia.
The North American and European cannabis markets have been estimated to reach a value of 80 billion USD by 2024.
International estimations such as this played a crucial part in motivating large scale corporations as Altria Group (owner of Phillip-Morris and the Marlboro brand), Constellation Brands Group (owner of ‘Corona’ beer), Imperial Brands Group (owner of the brands ‘drum’ and ‘winston’) and more, to place large scale investments amounting to billions of dollars, in Cannabis companies manufacturing Cannabis derived products.
BUSINESS MODEL
The company is currently examining a few business models, preferably leveraging resources and distribution capabilities of already existing corporations around the globe.
Such a business model will allow the company to take advantage of the high margins between production costs and revenues still common in most global target markets, thus producing relatively higher franchise and distribution royalties.
MEDICAL
Granting manufacturing & distribution
licences for THC products (EXTRA T) to local companies in Canada, California and other states in the US legalizing and regulating THC sales.
RECREATIONAL
Granting manufacturing & distribution
licences for CBD products (EXTRA C) to local distribution companies across Europe and the US, preferably collaborating with international cigarette manufacturers and distributors to market STICKIT as an additional private brand.
ONLINE SALES
Online sales to end customers in target markets via local distributor and according to local regulation.
FINANCIAL FORECAST
- Unique and exclusive technology transforming condensed cannabis derived oil into an innovative product.
- Controlled, consistent and precise way to use Cannabis for consumers’ various needs and preferences.
- Reliable international brand based on customer’s satisfaction and loyalty
- Consistent and continues company growth alongside the booming global Cannabis market. Strategic penetration to global target markets legalizing and regulating Cannabis.
- Collaborating and partnering with large scale global tobacco manufacturers and distributors who are looking into Cannabis market investments and creating a global reliable brand.
PUBLIC LISTING PLAN
The Company signed a LOI with a publicly traded company listed in Canada and is scheduled to be listed in Canadian stock exchange within 3 months.
Objectives
$5M Sales
within 24
months
5-7 worldwide
distribution
agreements
Completion of merger
into Canadian TSXV listed company, by Dec.2021
